See more : Dong Suh Companies Inc. (026960.KS) Income Statement Analysis – Financial Results
Complete financial analysis of InnovAge Holding Corp. (INNV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InnovAge Holding Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- EVRAZ PLC (EVZ.DE) Income Statement Analysis – Financial Results
- Hibiya Engineering, Ltd. (1982.T) Income Statement Analysis – Financial Results
- CYBERGUN BSA 2 (CYBBT.PA) Income Statement Analysis – Financial Results
- Indo Count Industries Limited (ICIL.BO) Income Statement Analysis – Financial Results
- Ace Edulink Co., Ltd. (6764.TWO) Income Statement Analysis – Financial Results
InnovAge Holding Corp. (INNV)
About InnovAge Holding Corp.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,850 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 763.86M | 688.09M | 698.64M | 637.80M | 567.19M | 465.63M |
| Cost of Revenue | 631.79M | 586.80M | 563.27M | 463.72M | 425.89M | 355.00M |
| Gross Profit | 132.06M | 101.29M | 135.37M | 174.08M | 141.30M | 110.63M |
| Gross Profit Ratio | 17.29% | 14.72% | 19.38% | 27.29% | 24.91% | 23.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 111.34M | 115.64M | 101.65M | 132.33M | 58.48M | 48.25M |
| Selling & Marketing | 24.96M | 19.63M | 24.20M | 22.24M | 19.00M | 16.46M |
| SG&A | 136.29M | 135.26M | 125.85M | 154.57M | 77.48M | 64.71M |
| Other Expenses | 18.95M | 124.00K | 13.92M | 30.51M | 12.21M | 6.24M |
| Operating Expenses | 155.24M | 150.68M | 139.78M | 185.07M | 89.69M | 70.95M |
| Cost & Expenses | 787.04M | 737.48M | 703.05M | 648.79M | 515.58M | 425.96M |
| Interest Income | 0.00 | 1.52M | 2.53M | 16.79M | 14.62M | 9.59M |
| Interest Expense | 4.02M | 1.52M | 2.53M | 16.79M | 14.62M | 9.59M |
| Depreciation & Amortization | 18.95M | 20.02M | 13.92M | 12.29M | 11.29M | 9.00M |
| EBITDA | 1.15M | -29.25M | 9.21M | -5.89M | 61.54M | 45.92M |
| EBITDA Ratio | 0.15% | -4.92% | 1.32% | 1.35% | 10.85% | 10.12% |
| Operating Income | -23.18M | -49.40M | -4.71M | -3.70M | 50.93M | 39.68M |
| Operating Income Ratio | -3.03% | -7.18% | -0.67% | -0.58% | 8.98% | 8.52% |
| Total Other Income/Expenses | 1.36M | -1.40M | -2.83M | -22.63M | -15.30M | -14.29M |
| Income Before Tax | -21.82M | -50.79M | -7.24M | -34.97M | 35.63M | 25.39M |
| Income Before Tax Ratio | -2.86% | -7.38% | -1.04% | -5.48% | 6.28% | 5.45% |
| Income Tax Expense | 1.40M | -7.24M | 723.00K | 9.77M | 9.87M | 6.32M |
| Net Income | -21.34M | -40.67M | -7.96M | -44.74M | 26.28M | 19.58M |
| Net Income Ratio | -2.79% | -5.91% | -1.14% | -7.01% | 4.63% | 4.20% |
| EPS | -0.16 | -0.30 | -0.06 | -0.33 | 0.20 | 0.15 |
| EPS Diluted | -0.16 | -0.30 | -0.06 | -0.33 | 0.20 | 0.15 |
| Weighted Avg Shares Out | 135.90M | 135.59M | 135.52M | 135.52M | 133.19M | 133.19M |
| Weighted Avg Shares Out (Dil) | 135.90M | 135.59M | 135.52M | 135.52M | 133.19M | 133.19M |
3 Healthcare Stocks to Sell Before Unionization Hurts Profits
InnovAge Names Darlene Flaig as New Chief Nursing Officer
InnovAge Holding Corp. (INNV) Q4 2023 Earnings Call Transcript
InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates
InnovAge Announces Financial Results For the Fourth Quarter and Fiscal Year Ended June 30, 2023
InnovAge Holding Corp. (INNV) Soars 15.4%: Is Further Upside Left in the Stock?
InnovAge to Announce Fiscal Fourth Quarter 2023 Financial Results and Host Conference Call Tuesday, September 12, 2023
InnovAge Strengthens Board with Appointment of New Independent Director
InnovAge Holding: EBITDA In Focus With No More Sanctions
InnovAge Gains Colorado New Enrollment Release But Growth May Be Slow
Source: https://incomestatements.info
Category: Stock Reports